CN1908003A - Method of synthesizing 9 alpha-bromine-11 beta-hydroxypregna-1,4,16-triene-3,20-diketone - Google Patents

Method of synthesizing 9 alpha-bromine-11 beta-hydroxypregna-1,4,16-triene-3,20-diketone Download PDF

Info

Publication number
CN1908003A
CN1908003A CN 200610052956 CN200610052956A CN1908003A CN 1908003 A CN1908003 A CN 1908003A CN 200610052956 CN200610052956 CN 200610052956 CN 200610052956 A CN200610052956 A CN 200610052956A CN 1908003 A CN1908003 A CN 1908003A
Authority
CN
China
Prior art keywords
bromo
triene
hydroxypregna
dione
diketone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200610052956
Other languages
Chinese (zh)
Inventor
章国林
俞永平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang University ZJU
Original Assignee
Zhejiang University ZJU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University ZJU filed Critical Zhejiang University ZJU
Priority to CN 200610052956 priority Critical patent/CN1908003A/en
Publication of CN1908003A publication Critical patent/CN1908003A/en
Pending legal-status Critical Current

Links

Landscapes

  • Steroid Compounds (AREA)

Abstract

9α-溴-11β-羟基孕甾-1,4,16-三烯-3,20-二酮合成法为医药化学领域。以孕甾-1,4,9(11),16-四烯-3,20-二酮为原料,在N-溴代酰胺、有机溶剂、高氯酸存在下,保留分子中的1,4,16位双键,选择性地对9(11)位双键进行羟溴化合成甾体化合物9α-溴-11β-羟基孕甾-1,4,16-三烯-3,20-二酮。本发明合成的甾体化合物9α-溴-11β-羟基孕甾-1,4,16-三烯-3,20-二酮未见国内外文献报道,为新化合物。所合成的步骤简单,反应条件温和,操作简便,收率高。The synthesis method of 9α-bromo-11β-hydroxypregna-1,4,16-triene-3,20-dione belongs to the field of medicinal chemistry. Using pregnane-1,4,9(11),16-tetraene-3,20-dione as raw material, in the presence of N-bromoamide, organic solvent and perchloric acid, retain 1,4 in the molecule , 16-position double bond, selective hydroxybromination of 9(11)-position double bond to synthesize steroidal compound 9α-bromo-11β-hydroxypregna-1,4,16-triene-3,20-dione . The steroidal compound 9α-bromo-11β-hydroxypregna-1,4,16-triene-3,20-dione synthesized by the invention has no domestic and foreign literature reports, and is a new compound. The synthesis steps are simple, the reaction conditions are mild, the operation is simple and the yield is high.

Description

9α-溴-11β-羟基孕甾-1,4,16-三烯-3,20-二酮合成法Synthesis of 9α-bromo-11β-hydroxypregna-1,4,16-triene-3,20-dione

技术领域technical field

本发明属于化学技术领域,涉及药物合成,具体为一种甾体抗炎药瑞美松龙(Rimexolone)的中间体9α-溴-11β-羟基孕甾-1,4,16-三烯-3,20-二酮的合成法。The invention belongs to the field of chemical technology, and relates to drug synthesis, specifically a steroidal anti-inflammatory drug Rimexolone intermediate 9α-bromo-11β-hydroxypregna-1,4,16-triene-3 , Synthesis of 20-diketones.

背景技术Background technique

11β-羟基孕甾-1,4,16-三烯-3,20-二酮(化合物3)是合成甾体抗炎药瑞美松龙(Rimexolone)的中间体,瑞美松龙具有抗炎、抗过敏功效高,副作用小,长期使用不会造成眼内压升高等优点,是目前唯一安全的眼科甾体抗炎药物。11β-羟基孕甾-1,4,16-三烯-3,20-二酮可以通过9α-溴-11β-羟基孕甾-1,4,16-三烯-3,20-二酮(化合物2)脱溴后得到。11β-hydroxypregna-1,4,16-triene-3,20-dione (compound 3) is an intermediate in the synthesis of the steroidal anti-inflammatory drug Rimexolone, which has anti-inflammatory properties , High anti-allergic effect, less side effects, long-term use will not cause intraocular pressure to rise, etc. It is the only safe ophthalmic steroidal anti-inflammatory drug at present. 11β-hydroxypregna-1,4,16-triene-3,20-dione can pass through 9α-bromo-11β-hydroxypregna-1,4,16-triene-3,20-dione (compound 2) Obtained after debromination.

本发明的目的是发明一种合成9α-溴-11β-羟基孕甾-1,4,16-三烯-3,20-二酮的方法。The object of the present invention is to invent a method for synthesizing 9α-bromo-11β-hydroxypregna-1,4,16-triene-3,20-dione.

发明内容Contents of the invention

我们以合成地塞米松的中间体孕甾-1,4,9(11),16-三烯-3,20-二酮(化合物1)为原料,在N-溴代酰胺、有机溶剂、高氯酸存在下,保留分子中的1,4,16位双键,选择性地对9(11)位双键进行羟溴化合成9α-溴-11β-羟基孕甾-1,4,16-三烯-3,20-二酮。We use the intermediate pregnane-1,4,9(11),16-triene-3,20-dione (compound 1) as raw material for the synthesis of dexamethasone in N-bromoamide, organic solvent, high In the presence of chloric acid, the 1, 4, 16 double bonds in the molecule are retained, and the 9 (11) double bonds are selectively hydroxybrominated to synthesize 9α-bromo-11β-hydroxypregna-1,4,16- Triene-3,20-dione.

上述N-溴代酰胺指N-溴代丁二酰亚胺,N-溴代乙酰胺其一。The aforementioned N-bromoamide refers to N-bromosuccinimide, one of N-bromoacetamides.

上述有机溶剂指四氢呋喃,二氧六环其一。The above-mentioned organic solvent refers to tetrahydrofuran, one of dioxane.

本发明合成的甾体化合物9α-溴-11β-羟基孕甾-1,4,16-三烯-3,20-二酮未见国内外文献报道,为新化合物。所合成的步骤简单,反应条件温和,操作简便,收率高。The steroidal compound 9α-bromo-11β-hydroxypregna-1,4,16-triene-3,20-dione synthesized by the present invention has no domestic and foreign literature reports, and is a new compound. The synthesis steps are simple, the reaction conditions are mild, the operation is simple and the yield is high.

具体实施方式Detailed ways

例1example 1

在反应瓶中加入孕甾-1,4,9(11),16-四烯-3,20-二酮(3.08g,0.01mol),四氢呋喃45毫升,N-溴代丁二酰亚胺(2.4g,0.013mol),28毫升0.64mol/L高氯酸水溶液,室温搅拌4小时。停止反应,往反应瓶中加入6毫升饱和亚硫酸钠溶液,减压浓缩除去四氢呋喃后加入200毫升水,搅拌1小时,析出固体,减压过滤,用100毫升水洗固体三次,真空干燥所得的固体用甲醇和二氯甲烷重结晶,得白色固体3.75g,收率为95%。mp:170℃(分解)。1H NMR(DMSO-d6):δ=1.15(s,3H),1.56(m,1H),1.69(s,3H),1.99(m,1H),2.05(m,2H),2.20(s,3H),2.22-2.40(m,5H),2.66-2.68(m,1H),4.55(s,1H),5.63(brs,1H),5.98(t,J=1.2Hz,1H),6.22(dd,J=1.6Hz,J=10Hz,1H),6.87(dd,J=1.2Hz,J=2.8Hz,1H),7.34(d,J=10Hz,1H)。MS:m/z=404(M+),406(M++2)。In the reaction flask, add pregna-1,4,9(11), 16-tetraene-3,20-dione (3.08g, 0.01mol), 45 milliliters of tetrahydrofuran, N-bromosuccinimide ( 2.4g, 0.013mol), 28ml of 0.64mol/L perchloric acid aqueous solution, stirred at room temperature for 4 hours. Stop the reaction, add 6 ml of saturated sodium sulfite solution to the reaction bottle, concentrate under reduced pressure to remove tetrahydrofuran, add 200 ml of water, stir for 1 hour, and precipitate a solid, filter under reduced pressure, wash the solid with 100 ml of water three times, dry the resulting solid with methanol Recrystallized with dichloromethane to obtain 3.75 g of white solid with a yield of 95%. mp: 170°C (decomposition). 1 H NMR (DMSO-d6): δ=1.15(s, 3H), 1.56(m, 1H), 1.69(s, 3H), 1.99(m, 1H), 2.05(m, 2H), 2.20(s, 3H), 2.22-2.40(m, 5H), 2.66-2.68(m, 1H), 4.55(s, 1H), 5.63(brs, 1H), 5.98(t, J=1.2Hz, 1H), 6.22(dd , J=1.6Hz, J=10Hz, 1H), 6.87 (dd, J=1.2Hz, J=2.8Hz, 1H), 7.34 (d, J=10Hz, 1H). MS: m/z = 404 (M + ), 406 (M + +2).

熔点由Büchi Melting Point B-540熔点仪测定,1HNMR由Bruker Avance DMX400核磁共振仪测定,质谱由GC-HP-5989质谱仪测定。The melting point was determined by a Büchi Melting Point B-540 melting point apparatus, the 1 HNMR was determined by a Bruker Avance DMX400 nuclear magnetic resonance instrument, and the mass spectrum was determined by a GC-HP-5989 mass spectrometer.

例2Example 2

在反应瓶中加入孕甾-1,4,9(11),16-四烯-3,20-二酮(3.08g,0.01mol),四氢呋喃45毫升,N-溴代乙酰胺(1.79g,0.013mol),28毫升0.64mol/L高氯酸水溶液,室温搅拌4小时。停止反应,往反应瓶中加入6毫升饱和亚硫酸钠溶液,减压浓缩除去四氢呋喃后加入200毫升水,搅拌1小时,析出固体,减压过滤,用100毫升水洗固体三次,真空干燥所得的固体用甲醇和二氯甲烷重结晶,得白色固体3.67g,收率为93%。In the reaction flask, add pregna-1,4,9(11), 16-tetraene-3,20-dione (3.08g, 0.01mol), 45 ml of tetrahydrofuran, N-bromoacetamide (1.79g, 0.013mol), 28 milliliters of 0.64mol/L perchloric acid aqueous solution, stirred at room temperature for 4 hours. Stop the reaction, add 6 ml of saturated sodium sulfite solution to the reaction bottle, concentrate under reduced pressure to remove tetrahydrofuran, add 200 ml of water, stir for 1 hour, and precipitate a solid, filter under reduced pressure, wash the solid with 100 ml of water three times, dry the resulting solid with methanol Recrystallized with dichloromethane to obtain 3.67 g of white solid with a yield of 93%.

例3Example 3

在反应瓶中加入孕甾-1,4,9(11),16-四烯-3,20-二酮(3.08g,0.01mol),二氧六环45毫升,N-溴代丁二酰亚胺(2.4g,0.013mol),28毫升0.64mol/L高氯酸水溶液,室温搅拌4小时。停止反应,往反应瓶中加入6毫升饱和亚硫酸钠溶液,减压浓缩除去四氢呋喃后加入200毫升水,搅拌1小时,析出固体,减压过滤,用100毫升水洗固体三次,真空干燥所得的固体用甲醇和二氯甲烷重结晶,得白色固体3.60g,收率为91%。In the reaction flask, add pregna-1,4,9(11), 16-tetraene-3,20-dione (3.08g, 0.01mol), 45 ml of dioxane, N-bromosuccinyl Imine (2.4 g, 0.013 mol), 28 ml of 0.64 mol/L perchloric acid aqueous solution, stirred at room temperature for 4 hours. Stop the reaction, add 6 ml of saturated sodium sulfite solution to the reaction bottle, concentrate under reduced pressure to remove tetrahydrofuran, add 200 ml of water, stir for 1 hour, and precipitate a solid, filter under reduced pressure, wash the solid with 100 ml of water three times, dry the resulting solid with methanol Recrystallized with dichloromethane to obtain 3.60 g of white solid with a yield of 91%.

例4Example 4

在反应瓶中加入孕甾-1,4,9(11),16-四烯-3,20-二酮(3.08g,0.01mol),二氧六环45毫升,N-溴代乙酰胺(1.79g,0.013mol),28毫升0.64mol/L高氯酸水溶液,室温搅拌4小时。停止反应,往反应瓶中加入6毫升饱和亚硫酸钠溶液,减压浓缩除去四氢呋喃后加入200毫升水,搅拌1小时,析出固体,减压过滤,用100毫升水洗固体三次,真空干燥所得的固体用甲醇和二氯甲烷重结晶,得白色固体3.65g,收率为92%。In the reaction flask, add pregna-1,4,9(11), 16-tetraene-3,20-dione (3.08g, 0.01mol), 45 milliliters of dioxane, N-bromoacetamide ( 1.79g, 0.013mol), 28ml of 0.64mol/L perchloric acid aqueous solution, stirred at room temperature for 4 hours. Stop the reaction, add 6 ml of saturated sodium sulfite solution to the reaction bottle, concentrate under reduced pressure to remove tetrahydrofuran, add 200 ml of water, stir for 1 hour, and precipitate a solid, filter under reduced pressure, wash the solid with 100 ml of water three times, dry the resulting solid with methanol Recrystallized with dichloromethane to obtain 3.65 g of white solid with a yield of 92%.

Claims (3)

1,9 α-bromo-11 beta-hydroxies pregnant steroid-1,4,16-triolefin-3,20-diketone synthesis method is characterized in that: with pregnant steroid-1,4,9 (11), 16-tetraene-3,20-diketone are raw material, in the presence of N-bromo-acid amide, organic solvent, perchloric acid, keep 1,4 in the molecule, 16 two keys optionally carry out hydroxyl bromination synthesizing steroid compound 9 α-bromo-11 beta-hydroxies pregnant steroid-1,4 to 9 (11) two keys, 16-triolefin-3, the 20-diketone.
2, by described 9 α of claim 1-bromo-11 beta-hydroxies pregnant steroid-1,4,16-triolefin-3,20-diketone synthesis method is characterized in that: described N-bromo-acid amide refers to the N-bromo-succinimide, N-bromo ethanamide one.
3, by described 9 α of claim 1-bromo-11 beta-hydroxies pregnant steroid-1,4,16-triolefin-3,20-diketone synthesis method is characterized in that: described organic solvent refers to tetrahydrofuran (THF), the dioxane one.
CN 200610052956 2006-08-15 2006-08-15 Method of synthesizing 9 alpha-bromine-11 beta-hydroxypregna-1,4,16-triene-3,20-diketone Pending CN1908003A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200610052956 CN1908003A (en) 2006-08-15 2006-08-15 Method of synthesizing 9 alpha-bromine-11 beta-hydroxypregna-1,4,16-triene-3,20-diketone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200610052956 CN1908003A (en) 2006-08-15 2006-08-15 Method of synthesizing 9 alpha-bromine-11 beta-hydroxypregna-1,4,16-triene-3,20-diketone

Publications (1)

Publication Number Publication Date
CN1908003A true CN1908003A (en) 2007-02-07

Family

ID=37699248

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200610052956 Pending CN1908003A (en) 2006-08-15 2006-08-15 Method of synthesizing 9 alpha-bromine-11 beta-hydroxypregna-1,4,16-triene-3,20-diketone

Country Status (1)

Country Link
CN (1) CN1908003A (en)

Similar Documents

Publication Publication Date Title
JP5657052B2 (en) Use of pregnane and androstane steroids for the manufacture of pharmaceutical compositions for the treatment of CNS diseases
US10233210B2 (en) Process for preparation of glucocorticoid steroids
DE3783007T2 (en) 9-ALPHA HYDROXYSTEROIDS, METHOD FOR THE PRODUCTION THEREOF AND METHOD FOR THE PRODUCTION OF THE CORRESPONDING 9 (11) -DEHYDRO DERIVATIVES.
CN101223186A (en) Process for the preparation of 3-oxo-pregn-4-en-21, 17-olides by metal-free oxidation of 17- (3-hydroxypropyl) -3, 17-dihydroxyandrostanes
Nathansohn et al. Steroids possessing nitrogen atoms. III. Synthesis of new highly active corticoids.[17α, 16α,-d] oxazolino steroids
ES2351184T3 (en) PROCEDURE FOR THE PRODUCTION OF 16.17 - [(CICLOHEXILMETILEN) BIS (OXIL)] - 11,21-DIHYDROXI-PREGNA-1,4-DIEN-3,20-DIONA OR ITS 21-ISOBUTIRATE THROUGH TRANSCETALIZATION.
CN107400153A (en) A kind of preparation method of hydrocortisone acetate
CN102558273A (en) Method for preparing fluticasone furoate
CN1908003A (en) Method of synthesizing 9 alpha-bromine-11 beta-hydroxypregna-1,4,16-triene-3,20-diketone
BRPI0619428A2 (en) Process 17α-cyanomethyl-17 (beta) -hydroxy-estra-4,9-diene-3-one for the synthesis thereof
CN109438538A (en) A kind of synthetic method of -17 beta-hydroxy -3- ketone of -17 Alpha-Methyl of Stanozolol intermediate androstane
CN103772468A (en) Preparation methods and purposes of Proellex(R)-V and intermediate of Proellex(R)-V
CN104231025B (en) A kind of estrone bulk drug impurity and preparation method thereof and the purposes as standard items
KR20100063370A (en) Method for preparing rocuronium bromide
CN109134576B (en) Method for synthesizing lithocholic acid by taking hyodeoxycholic acid as raw material
CN106518939B (en) Method for preparing Solithromycin compound
EP1575983A1 (en) 17.beta-[alpha-hydroxy]-esters of androstanes as intermediates for the preparation of 17.beta.-fluorinated-androstane esters
CH494216A (en) Process for the preparation of 6-aminomethyl-3,5-steroids bearing an etherified hydroxyl group in the 3-position
DE2603545C3 (en) New 16 a -Methyl-17 a - bromo-prednisolone- and prednisone derivatives and processes for their preparation
CN120484042B (en) A method for synthesizing HE3286
CN119529013B (en) Synthesis method of Zu Lanuo dragon intermediate
CN102040646A (en) Synthetic process for preparing 6alpha-fluoro steroids by using NFTh fluorinating agent
CN104292287A (en) Synthesizing method of 17-ethinyl-16-ene steroid derivative
CN104292288A (en) Preparation method of 17-ethinyl-16-ene steroid derivative
JPH036158B2 (en)

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication